Join us on Monday, April 21, 2025, at 3:00 PM PST | 6:00 PM EST for GLI’s Liver Cancer Lessons: Liver Disease Prevention Through Nutrition, an educational webinar that discusses the impact nutrition has on liver health.
Global Liver Institute
GLOBAL LIVER INSTITUTE
Meet Our New Fatty Liver Disease Program Director! – Fatty Liver Disease News
Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program Director.
MiKayla Chapman’s Experience with the Rare Science Fairs – Pediatric and Rare Liver Diseases News
Growing up in rural Mississippi, MiKayla believed that opportunities in science were reserved for people from well-connected backgrounds.
Proactive Protection of the Liver Health of Asian Americans
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can cause long-term (chronic) disease. Chronic hepatitis B can lead to serious liver damage – including scarring (cirrhosis), liver failure, and even liver cancer.
Global Liver Institute and King’s College Hospital NHS Foundation Trust Launch First UK-Based Advanced Advocacy Academy to Strengthen Liver Health Education and Awareness
Global Liver Institute (GLI) and King’s College Hospital NHS Foundation Trust (KCH) are proud to announce the first Advanced Advocacy Academy (A3) in the United Kingdom, an innovative program dedicated to increasing education, awareness, and advocacy for liver health.
Congress grapples with budget and appropriations while the administration eliminates funding for health programs and terminates federal employees. – Liver Health Policy Update
The situation in Congress remains unclear as the House budget resolution calls for possible significant Medicaid cuts, while the Senate attempts to steer clear of policies reducing Medicaid and/or Medicare benefits.
Beyond the Diagnosis: Stories, Breakthroughs & Global Action – Fatty Liver Disease News
As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.
How to Stay Engaged Beyond Rare Liver Diseases Month – Pediatric and Rare Liver Diseases News
February is Rare Liver Diseases Month! This year, our campaign is shining a spotlight on Rare and Rural.
Advances in Liver Cancer Treatment & Research – Liver Cancer News
Liver cancer continues to be a growing public health concern, with new research and treatment innovations shaping the future of care. This newsletter brings you the latest advancements in the field, including promising therapies, diagnostic breakthroughs, and discussions on the rising impact of metabolic and alcohol-related liver diseases. Stay informed with expert insights and emerging strategies that could improve patient outcomes.
How the Hepatitis C Cure Affects Other Chronic Conditions
Hepatitis C infection is a chronic infection of the liver by the hepatitis C virus (HCV) that continues to affect millions of people across the globe. Left untreated, infection with hepatitis C leads to worsening liver damage and puts the body in distress, which can lead to brain fog, abdominal pain, and internal bleeding.
New Administration, New Congress, and Their Health Priorities Just Starting to Take Shape – Liver Health Policy Update
The new U.S. Congress is at work in Washington, DC. It is unclear if the healthcare legislation that came so close to passage last December will be included in a March appropriations package.
It’s Rare Liver Diseases Month! – Pediatric & Rare Liver Diseases News
February is Rare Liver Diseases Month! This year, our campaign is shining a spotlight on Rare and Rural.